Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Correction to Advanced Cancer Immunotherapy via SMARCAL1 Blockade Using a Glucose-Responsive CRISPR Nanovaccine.
Published: 202510.1002/advs.202520638
No abstract available for this study.
No abstract available for this study.